Wall Street Experts
ver. ZuMIgo(08/25)
Prognozy (mln) dla Korea United Pharm Inc.
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
| Przychód (średnia) |
302,300.00 |
300,000.00 |
317,100.00 |
317,100.00 |
| Przychód Δ r/r |
0.00% |
-0.76% |
5.70% |
0.00% |
| Przychód (min) |
302,300.00 |
300,000.00 |
317,100.00 |
317,100.00 |
| Przychód (max) |
302,300.00 |
300,000.00 |
317,100.00 |
317,100.00 |
| EBITDA (średnia) |
66,662.30 |
66,155.11 |
69,925.95 |
69,925.95 |
| EBIT (średnia) |
55,707.99 |
55,284.14 |
58,435.34 |
58,435.34 |
| EBIT % |
18.43% |
18.43% |
18.43% |
18.43% |
| Zysk netto (średni) |
58,728.59 |
54,664.13 |
57,064.52 |
50,290.41 |
| Zysk netto % |
19.43% |
18.22% |
18.00% |
15.86% |
| EPS (średnia) |
3988.00 |
3712.00 |
3875.00 |
3415.00 |
| Liczba analityków (Przychody) |
1 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
1 |
1 |
| symbol |
033270.KS |
033270.KS |
033270.KS |
033270.KS |